Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms, Plasma Cell 2Multiple Myeloma 2cyclopia sequence 1Tobacco Use Cessation 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nocturia 1Myelodysplastic Syndromes 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hodgkin Disease 1Health Education 1Head and Neck Neoplasms 1Fatigue 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Modafinil 2isoquercitrin 1Valganciclovir 1Tai Ji 1Surveys and Questionnaires 1Sunitinib 1Sugars 1Qigong 1Psychiatric Rehabilitation 1Massage 1Homeopathy 1Exercise Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Fatigue × Surveys and Questionnaires × Clear all
NCT01330446 2024-02-14

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Head & Neck

Fatigue, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡